Blood pressure recall: FDA recalls 580K bottles made by Teva Pharmaceuticals

You might want to take another look at your medicine cabinet.

More than 580,000 bottles of a type of blood pressure medication have been recalled due to the potential presence of cancer-causing chemicals, according to the U.S. Food and Drug Administration.

The New Jersey-based Teva Pharmaceuticals recalled the Prazosin Hydrochloride capsules because they had “above acceptable intake limits” for N-nitroso Prazosin impurity C, a known carcinogen.

No adverse affects have been reported to date.

READ MORE: FDA recalls more than 140K bottles of this common statin: Is your medication one of them?

Here’s what you need to know about which capsules are part of the recall and what you should do if you have the recalled medication.

Which Prazosin Hydrochloride capsules were subject to the recall?

The 580,844 bottles of Prazosin Hydrochloride capsules were distributed nationwide and came in 1, 2 and 5 milligram doses, according to the FDA.

A total of 55 lots of the medication were recalled, with lot codes listed on the FDA notice.

According to the FDA, the pills were first recalled on Oct. 7 and then classified as a Class II recall on Oct. 24.

A Class II recall means that the “product may cause temporary or medically reversible adverse health consequences.”

What should people do if they have the recalled Prazosin Hydrochloride capsules?

Teva told NBC Chicago it sent letters about the recall to affected customers with instructions for returning the recalled medication.

In the meantime, those with the medication are advised to contact their pharmacies for further guidance on what to do with the rest of the recalled medication.

“In addition, consumers with questions or concerns should also contact the health care provider who prescribed the medication,” Teva said.